News | May 22, 2023
GlaxoSmithKline Pharmaceuticals posts consolidated Q4 FY2023 PAT at Rs. 133.43 Cr
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
The Theme of the event was 'Building One Health Together – Improving Health Equity'
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
This sBLA submission is supported by clinical, pre-clinical, and manufacturing data demonstrating the safety, tolerability, and immunogenicity of the bivalent vaccine.
Clinical studies are expected to start in Q2 2023.
Subscribe To Our Newsletter & Stay Updated
